Mark S. Md Gelder Onconova Therapeutics, Inc. (ONTX) insider trading activity

ONTX Quotes by TradingView

Mark S. Md Gelder is CHIEF MEDICAL OFFICER of Onconova Therapeutics, Inc.. Currently has a direct ownership of 10,487 shares of ONTX, which is worth approximately $6,187. The most recent transaction as insider was on Feb 07, 2023, when has been sold 1,242 shares (Common Stock) at a price of $1.36 per share, resulting in proceeds of $1,689. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.5K
0% 3M change
0% 12M change
Total Value Held $6,187

Mark S. MD Gelder Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 07 2023
SELL
Payment of exercise price or tax liability
$1,689 $1.36 p/Share
1,242 Reduced 10.59%
10,487 Common Stock
Feb 07 2023
BUY
Exercise of conversion of derivative security
-
5,833 Added 33.21%
11,729 Common Stock
Aug 03 2022
SELL
Payment of exercise price or tax liability
$1,498 $1.32 p/Share
1,135 Reduced 16.14%
5,896 Common Stock
Aug 02 2022
BUY
Exercise of conversion of derivative security
-
4,650 Added 39.81%
7,031 Common Stock
Sep 28 2021
BUY
Open market or private purchase
$10,000 $4.2 p/Share
2,381 Added 50.0%
2,381 Common Stock
MSM

Mark S. Md Gelder

CHIEF MEDICAL OFFICER
Newtown, PA

Track Institutional and Insider Activities on ONTX

Follow Onconova Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONTX shares.

Notify only if

Insider Trading

Get notified when an Onconova Therapeutics, Inc. insider buys or sells ONTX shares.

Notify only if

News

Receive news related to Onconova Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ONTX